BANDARAM PHARMA PACKTECH LIMIT
Latest filings
Next results: Thu, 29 Oct · Financial Results- Board meeting set for September 2026 quarter results · Results
- RTA certificate under SEBI Regulation 74(5) filed with BSE · Compliance
- Board meeting scheduled for 30 Sep 2026 has been cancelled · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
Supplies paper, board, and printing materials used in textbook printing through its material subsidiary VSR Paper and Packaging Limited (55% held), and is classified as a healthcare service provider. In FY26, consolidated revenue grew 70% year-on-year to Rs. 62.9232 crore, with consolidated net profit of Rs. 0.2815 crore. Materials cost 87.4% of revenue. Recent orders include Rs. 37.44 crore from the Government of Telangana covering 32.75 lakh textbooks and 99,554 textbooks for academic year 2026-27, Rs. 5.87 crore from Vijayaa Print Solutions, and Rs. 3.87 crore from S.A. Printers, all for execution between June and August 2026. The consolidated auditor issued a qualified opinion because VSR Paper and Packaging netted trade receivables against payables without adequate supporting documentation. The company also owns 100% of Craftsmart Products, acquired via a share swap, and standalone FY26 revenue stood at Rs. 6,292.32 lakhs, up 70% year-on-year.
Scorecard
Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice
Strengths
Nothing stands out in the filed numbers.Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from BANDARAM PHARMA PACKTECH LIMIT's filed financials and exchange disclosures
What does BANDARAM PHARMA PACKTECH LIMIT do?
BANDARAM PHARMA PACKTECH LIMIT is a Healthcare Services company listed on BSE.
Is BANDARAM PHARMA PACKTECH LIMIT profitable?
Yes. Over the trailing twelve months BANDARAM PHARMA PACKTECH LIMIT reported a net profit of ₹0.54 Cr on revenue of ₹63 Cr.
Does BANDARAM PHARMA PACKTECH LIMIT pay a dividend?
Not in the latest reported year — BANDARAM PHARMA PACKTECH LIMIT's dividend payout for FY26 was nil.
Is BANDARAM PHARMA PACKTECH LIMIT debt-free?
No. It reported borrowings of ₹24 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹23 Cr after cash. Debt stands at 0.76× equity. That is higher than 91% of its 23 Healthcare Service Provider peers.
Is BANDARAM PHARMA PACKTECH LIMIT expensive compared with its peers?
On trailing P/E, BANDARAM PHARMA PACKTECH LIMIT ranks 23 of 25 in Healthcare Service Provider — cheaper than 8% of them, against an industry median of 23.4×. This is a position, not a valuation judgement.
How much does the BANDARAM PHARMA PACKTECH LIMIT share price move in a day?
On a typical session BANDARAM PHARMA PACKTECH LIMIT moves 2.26% — that is the median absolute close-to-close move across its last 266 trading days. MarketPing measures each filing's price reaction against it.
When are BANDARAM PHARMA PACKTECH LIMIT's next results?
Financial Results on Thu, 29 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track BANDARAM PHARMA PACKTECH LIMIT's announcements?
Every NSE and BSE filing by BANDARAM PHARMA PACKTECH LIMIT appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.